awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38192680-24F72172-8065-4C97-94EE-25F9552B8ECE
Q38192680-24F72172-8065-4C97-94EE-25F9552B8ECE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38192680-24F72172-8065-4C97-94EE-25F9552B8ECE
New therapeutic options for advanced forms of thyroid cancer.
P2860
Q38192680-24F72172-8065-4C97-94EE-25F9552B8ECE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38192680-24F72172-8065-4C97-94EE-25F9552B8ECE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dc12d7623582e05ce24647f46030bd6f3e407d8a
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr